-
1
-
-
77049317231
-
A post-myocardial infarction syndrome: Preliminary report of a complication resembling idiopathic, recurrent, benign pericarditis
-
Dressler W. A post-myocardial infarction syndrome: preliminary report of a complication resembling idiopathic, recurrent, benign pericarditis. JAMA 1956; 160:1379-1383
-
(1956)
JAMA
, vol.160
, pp. 1379-1383
-
-
Dressler, W.1
-
2
-
-
70449235780
-
The post-myocardial infarction syndrome
-
Dressler W. The post-myocardial infarction syndrome. Arch Intern Med 1959; 103:28-42
-
(1959)
Arch Intern Med
, vol.103
, pp. 28-42
-
-
Dressler, W.1
-
4
-
-
0020644699
-
Characteristics, prevalence, and prognosis of postmyocardial infarction syndrome
-
Welin L, Vedin A, Wilhelmsson C. Characteristics, prevalence, and prognosis of postmyocardial infarction syndrome. Br Heart J 1983; 50:140-145
-
(1983)
Br Heart J
, vol.50
, pp. 140-145
-
-
Welin, L.1
Vedin, A.2
Wilhelmsson, C.3
-
5
-
-
0021332439
-
Evidence for the continued existence of the postmyocardial infarction (Dressler's) syndrome
-
Northcote RJ, Hutchison SJ, McGuinness JB. Evidence for the continued existence of the postmyocardial infarction (Dressler's) syndrome. Am J Cardiol 1984; 53:1201-1202
-
(1984)
Am J Cardiol
, vol.53
, pp. 1201-1202
-
-
Northcote, R.J.1
Hutchison, S.J.2
McGuinness, J.B.3
-
6
-
-
0027424433
-
The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
-
GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329:1615-1622
-
(1993)
N Engl J Med
, vol.329
, pp. 1615-1622
-
-
-
7
-
-
0032574633
-
Extended mortality benefit of early postinfarction reperfusion: GUSTO-I Angiographic Investigators; Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial
-
Ross AM, Coyne KS, Moreyra E, et al. Extended mortality benefit of early postinfarction reperfusion: GUSTO-I Angiographic Investigators; Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial. Circulation 1998; 97:1549-1556
-
(1998)
Circulation
, vol.97
, pp. 1549-1556
-
-
Ross, A.M.1
Coyne, K.S.2
Moreyra, E.3
-
8
-
-
0037187893
-
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction
-
Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002; 346:957-966
-
(2002)
N Engl J Med
, vol.346
, pp. 957-966
-
-
Stone, G.W.1
Grines, C.L.2
Cox, D.A.3
-
9
-
-
0027931119
-
Disappearance of a syndrome: Dressler's syndrome in the era of thrombolysis
-
Shahar A, Hod H, Barabash GM, et al. Disappearance of a syndrome: Dressler's syndrome in the era of thrombolysis. Cardiology 1994; 85:255-258
-
(1994)
Cardiology
, vol.85
, pp. 255-258
-
-
Shahar, A.1
Hod, H.2
Barabash, G.M.3
-
10
-
-
0020454850
-
Current incidence of postmyocardial infarction (Dressler's) syndrome
-
Lichstein E, Arsura E, Hollander G, et al. Current incidence of postmyocardial infarction (Dressler's) syndrome. Am J Cardiol 1982; 50:1269-1271
-
(1982)
Am J Cardiol
, vol.50
, pp. 1269-1271
-
-
Lichstein, E.1
Arsura, E.2
Hollander, G.3
-
11
-
-
0015230058
-
Pericarditis after acute myocardial infarction
-
Thadani U, Chopra MP, Aber CP, et al. Pericarditis after acute myocardial infarction. BMJ 1971; 2:135-137
-
(1971)
BMJ
, vol.2
, pp. 135-137
-
-
Thadani, U.1
Chopra, M.P.2
Aber, C.P.3
-
12
-
-
0022003064
-
Complement activation after myocardial infarction
-
Earis JE, Marcuson EC, Bernstein A. Complement activation after myocardial infarction. Chest 1985; 87:186-190
-
(1985)
Chest
, vol.87
, pp. 186-190
-
-
Earis, J.E.1
Marcuson, E.C.2
Bernstein, A.3
-
13
-
-
0019867733
-
Reappraisal of the postmyocardial infarction Dressler's syndrome
-
Kossowsky WA, Lyon AF, Spain DM. Reappraisal of the postmyocardial infarction Dressler's syndrome. Am Heart J 1981; 102:954-956
-
(1981)
Am Heart J
, vol.102
, pp. 954-956
-
-
Kossowsky, W.A.1
Lyon, A.F.2
Spain, D.M.3
-
14
-
-
0021259538
-
Left ventricular mural thrombi complicating acute myocardial infarction: Long-term follow-up with serial echocardiography
-
Weinreich DJ, Burke JF, Pauletto FJ. Left ventricular mural thrombi complicating acute myocardial infarction: long-term follow-up with serial echocardiography. Ann Intern Med 1984; 100:789-794
-
(1984)
Ann Intern Med
, vol.100
, pp. 789-794
-
-
Weinreich, D.J.1
Burke, J.F.2
Pauletto, F.J.3
-
15
-
-
0027161727
-
Comparison of frequency, diagnostic and prognostic significance of pericardial involvement in acute myocardial infarction treated with and without thrombolytics: Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)
-
Correale E, Maggioni AP, Romano S, et al. Comparison of frequency, diagnostic and prognostic significance of pericardial involvement in acute myocardial infarction treated with and without thrombolytics: Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI). Am J Cardiol 1993; 71:1377-1381
-
(1993)
Am J Cardiol
, vol.71
, pp. 1377-1381
-
-
Correale, E.1
Maggioni, A.P.2
Romano, S.3
-
16
-
-
0028144938
-
Effect of definition on incidence of postinfarction pericarditis: It is time to redefine postinfarction pericarditis?
-
Oliva PB, Hammill SC, Talano JV. Effect of definition on incidence of postinfarction pericarditis: it is time to redefine postinfarction pericarditis? Circulation 1994; 90:1537-1541
-
(1994)
Circulation
, vol.90
, pp. 1537-1541
-
-
Oliva, P.B.1
Hammill, S.C.2
Talano, J.V.3
-
17
-
-
0016141089
-
Soluble-complex formation after myocardial infarction
-
Versey JM, Gabriel R. Soluble-complex formation after myocardial infarction. Lancet 1974; 2:493-494
-
(1974)
Lancet
, vol.2
, pp. 493-494
-
-
Versey, J.M.1
Gabriel, R.2
-
18
-
-
0026665361
-
ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts
-
Linz W, Wiemer G, Scholkens BA. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts. J Mol Cell Cardiol 1992; 24:909-919
-
(1992)
J Mol Cell Cardiol
, vol.24
, pp. 909-919
-
-
Linz, W.1
Wiemer, G.2
Scholkens, B.A.3
-
19
-
-
0033406821
-
Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure
-
Gullestad L, Aukrust P, Ueland T, et al. Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. J Am Coll Cardiol 1999; 34:2061-2067
-
(1999)
J Am Coll Cardiol
, vol.34
, pp. 2061-2067
-
-
Gullestad, L.1
Aukrust, P.2
Ueland, T.3
-
20
-
-
0034595362
-
Beta-adrenergic blockade in developing heart failure: Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling
-
Prabhu SD, Chandrasekar B, Murray DR, et al. Beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 2000; 101:2103-2109
-
(2000)
Circulation
, vol.101
, pp. 2103-2109
-
-
Prabhu, S.D.1
Chandrasekar, B.2
Murray, D.R.3
-
21
-
-
0034533147
-
Statins as a newly recognized type of immunomodulator
-
Kwak B, Mulhaupt F, Myit S, et al. Statins as a newly recognized type of immunomodulator. Nat Med 2000; 6:1399-1402
-
(2000)
Nat Med
, vol.6
, pp. 1399-1402
-
-
Kwak, B.1
Mulhaupt, F.2
Myit, S.3
-
22
-
-
0035133351
-
Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy
-
Ohtsuka T, Hamada M, Hiasa G, et al. Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy. J Am Coll Cardiol 2001; 37:412-417
-
(2001)
J Am Coll Cardiol
, vol.37
, pp. 412-417
-
-
Ohtsuka, T.1
Hamada, M.2
Hiasa, G.3
-
23
-
-
0029157002
-
Cardiac release of cytokines and inflammatory responses in acute myocardial infarction
-
Neumann FJ, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995; 92:748-755
-
(1995)
Circulation
, vol.92
, pp. 748-755
-
-
Neumann, F.J.1
Ott, I.2
Gawaz, M.3
-
24
-
-
0034704893
-
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
-
Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342:836-843
-
(2000)
N Engl J Med
, vol.342
, pp. 836-843
-
-
Ridker, P.M.1
Hennekens, C.H.2
Buring, J.E.3
-
25
-
-
0035963529
-
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
-
Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; 344:1959-1965
-
(2001)
N Engl J Med
, vol.344
, pp. 1959-1965
-
-
Ridker, P.M.1
Rifai, N.2
Clearfield, M.3
-
26
-
-
0037134842
-
Systemic inflammation in unstable angina is the result of myocardial necrosis
-
Cusack MR, Marber MS, Lambiase PD, et al. Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol 2002; 39:1917-1923
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 1917-1923
-
-
Cusack, M.R.1
Marber, M.S.2
Lambiase, P.D.3
-
27
-
-
0037093893
-
Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia
-
Kinlay S, Timms T, Clark M, et al. Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia. Am J Cardiol 2002; 89:1205-1207
-
(2002)
Am J Cardiol
, vol.89
, pp. 1205-1207
-
-
Kinlay, S.1
Timms, T.2
Clark, M.3
-
28
-
-
0035804846
-
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial
-
Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001; 285:1711-1718
-
(2001)
JAMA
, vol.285
, pp. 1711-1718
-
-
Schwartz, G.G.1
Olsson, A.G.2
Ezekowitz, M.D.3
-
29
-
-
0036239382
-
Early initiation of treatment with statins in acute coronary syndromes
-
Olsson AG, Schwartz GG. Early initiation of treatment with statins in acute coronary syndromes. Ann Med 2002; 34:37-41
-
(2002)
Ann Med
, vol.34
, pp. 37-41
-
-
Olsson, A.G.1
Schwartz, G.G.2
-
30
-
-
0035806626
-
Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study
-
Albert MA, Danielson E, Rifai N, et al. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 2001; 286:64-70
-
(2001)
JAMA
, vol.286
, pp. 64-70
-
-
Albert, M.A.1
Danielson, E.2
Rifai, N.3
-
31
-
-
0037032276
-
Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: An experimental serial cardiac magnetic resonance imaging study
-
Nahrendorf M, Hu K, Hiller KH, et al. Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: an experimental serial cardiac magnetic resonance imaging study. J Am Coll Cardiol 2002; 40:1695-1700
-
(2002)
J Am Coll Cardiol
, vol.40
, pp. 1695-1700
-
-
Nahrendorf, M.1
Hu, K.2
Hiller, K.H.3
|